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Editorial
Gene Diagnostics — A Challenge for Clinical Chemistry?
Gene technology has greatly improved the prenatal diagnosis of sickle-cell anaemia and other haemoglobino-
pathies in recent years. Using DNA-probes or oligonucleotides the analysis for mutations can be carried out
after 8 — 10 weeks of pregnancy with chorionic villi samples or after 16 weeks of pregnancy with amniotic
fluid. DNA recombinant technique is now spreading so fast that other common inherited disorders may
be analysed in the near future. The fact that restriction fragment length polymorphisms (RFLPs) can be
used äs genetic markers has opened up a new dimension for the study of the human genome. This technology
is becoming increasingly applicable to the detection and diagnosis of other important monogenic disorders —
even where the biochemical defect is not yet understood. Diseases such äs cystic fibrosis, Duchenne's muscular
dystrophy, Huntingtorfs chorea, steroid 21-hydroxylase deficiency, X-linked retinopathies, haemophilia A
and B are now amenable for gene diagnostic study if a DNA sample is available from an affected or normal
sib in the farnily. Genetic markers could also be used in the prediction of atherosclerosis, diabetes mellitus
and even risk factors of otherwise undetectable multigenic diseases. Techniques that are currently being
developed, such äs non-radioactive detection of DNA sequences and pulse field electrophoresis for the
Separation of DNA molecules up to several million basepairs will play an increasing role in the future. The
new aspects have been discussed at the 2. Annual Meeting of the Arbeitsgemeinschaft für Gen-Diagnostik
e. V., the abstracts of which are part of this issue.
For the classical clinical chemist, gene techniques may merely mean the introduction of a new analytical
technique like radioimmunoassay, isoelectric focusing or cell differentiation by surface markers. This view
however, ignores the potential of gene analytical techniques. Besides opening the possibility of replacing
hitherto measured products by direct gene analysis, these methods allow for qualitative results long before
gene products are formed and the abnormality or disease is expressed.
For this reason the questipns may be raised "what should be measured", "when should be measured" and
"in what kind of population" leading to general ethical problems which cannot be solved by the gene analyst
alone.
It is hoped that this and the forthcoming annual meetings of the "Arbeitsgemeinschaft für Gen-Diagnostik
e. V." provide a glimpse of the potential molecular approach to disease and allow interdisciplinary discussions
about the technical, medical, ethical and social aspects of the new technology.
A recent repprt of the Enqüete-commission: "Chances and Risks of Gene Technology" (Drucksache 10/6775
of Deutscher Bundestag 6. 1. 1987) summarizes the possibilities and gives recommendations for limitations
of gene analysis in prenatal and postnatal diagnosis, in the screening of employees and in insurance screening
äs well äs in jiuisdiction.
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